Skip to main content

Coronary Anomaly Management Program (CAMP) News

Your child's team will include a cardiothoracic surgeon, an adult congenital heart disease specialist and cardiologists, each with special training in caring for patients with coronary anomalies. We make sure your child gets the highest level of care.

Contact us

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top